Parkside Financial Bank & Trust’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.3K Buy
674
+7
+1% +$307 ﹤0.01% 1140
2025
Q4
$25.8K Buy
667
+35
+6% +$1.33K ﹤0.01% 1217
2025
Q3
$22.3K Sell
632
-14
-2% -$507 ﹤0.01% 1207
2025
Q2
$23.3K Buy
646
+12
+2% +$398 ﹤0.01% 1179
2025
Q1
$19.7K Buy
634
+221
+54% +$7K ﹤0.01% 1152
2024
Q4
$10.5K Buy
413
+82
+25% +$2.17K ﹤0.01% 1255
2024
Q3
$9.36K Buy
331
+12
+4% +$332 ﹤0.01% 1265
2024
Q2
$8.43K Buy
319
+29
+10% +$804 ﹤0.01% 1233
2024
Q1
$8.81K Sell
290
-3
-1% -$88 ﹤0.01% 1210
2023
Q4
$8.22K Buy
293
+158
+117% +$4.34K ﹤0.01% 1187
2023
Q3
$3.66K Buy
135
+59
+78% +$1.75K ﹤0.01% 1477
2023
Q2
$2.34K Buy
76
+48
+171% +$1.63K ﹤0.01% 1642
2023
Q1
$1.01K Sell
28
-58
-67% -$2.15K ﹤0.01% 1846
2022
Q4
$3.4K Hold
86
﹤0.01% 1485
2022
Q3
$3K Hold
86
﹤0.01% 1446
2022
Q2
$4K Hold
86
﹤0.01% 1365
2022
Q1
$3K Buy
86
+11
+15% +$432 ﹤0.01% 1523
2021
Q4
$3K Buy
75
+70
+1,400% +$2.72K ﹤0.01% 1528
2021
Q3
$0 Sell
5
-24
-83% -$933 ﹤0.01% 1835
2021
Q2
$1K Buy
+29
New +$1.23K ﹤0.01% 1658

Other funds holding RPRX

Parkside Financial Bank & Trust's RPRX Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Royalty Pharma (RPRX) stake by 1% in Q1 2026, buying an estimated $307 and bringing the position to 674 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1140.

Parkside Financial Bank & Trust first reported a position in RPRX in Q2 2021 and has held it in 20 quarters since. 590 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Parkside Financial Bank & Trust held 674 shares of Royalty Pharma worth $32.3K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 7 Royalty Pharma shares in Q1 2026, an estimated $307.
  • Royalty Pharma made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1140 holding.
  • Parkside Financial Bank & Trust first reported a position in Royalty Pharma in Q2 2021 and has held it in 20 quarters since.
  • 590 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.